ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.530
-0.035 (-2.24%)
At close: Jun 26, 2026, 4:00 PM EDT
1.559
+0.029 (1.87%)
After-hours: Jun 26, 2026, 7:29 PM EDT
ProQR Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ProQR Therapeutics stock have an average target of 8.00, with a low estimate of 3.00 and a high estimate of 12. The average target predicts an increase of 422.88% from the current stock price of 1.53.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ProQR Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Buy Reiterates $4 → $3 | Buy | Reiterates | $4 → $3 | +96.08% | Jun 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +684.31% | May 13, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $8 | Buy | Maintains | $8 | +422.88% | Apr 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $9 | Buy | Reiterates | $9 | +488.24% | Apr 9, 2026 |
| Citizens JMP | Citizens JMP | Buy Reiterates $8 | Buy | Reiterates | $8 | +422.88% | Mar 12, 2026 |
Financial Forecast
Revenue This Year
13.43M
from 16.35M
Decreased by -17.86%
Revenue Next Year
14.37M
from 13.43M
Increased by 7.03%
EPS This Year
-0.53
EPS Next Year
-0.59
from -0.53
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.8M | 27.3M | |
| Avg | 13.4M | 14.4M | |
| Low | 2.0M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.9% | 103.1% | |
| Avg | -17.9% | 7.0% | |
| Low | -87.8% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.53 | -0.59 | |
| Avg | -0.53 | -0.59 | |
| Low | -0.53 | -0.59 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.